132 related articles for article (PubMed ID: 10683317)
21. ST3Gal III modulates breast cancer cell adhesion and invasion by altering the expression of invasion-related molecules.
Cui HX; Wang H; Wang Y; Song J; Tian H; Xia C; Shen Y
Oncol Rep; 2016 Dec; 36(6):3317-3324. PubMed ID: 27779707
[TBL] [Abstract][Full Text] [Related]
22. CMP substitutions preferentially inhibit polysialic acid synthesis.
Miyazaki T; Angata K; Seeberger PH; Hindsgaul O; Fukuda M
Glycobiology; 2008 Feb; 18(2):187-94. PubMed ID: 18077550
[TBL] [Abstract][Full Text] [Related]
23. Hormonal regulation of pituitary FSH sialylation in male rats.
Ambao V; Rulli SB; Carino MH; Cónsole G; Ulloa-Aguirre A; Calandra RS; Campo S
Mol Cell Endocrinol; 2009 Oct; 309(1-2):39-47. PubMed ID: 19464343
[TBL] [Abstract][Full Text] [Related]
24. ST3Gal.I sialyltransferase relevance in bladder cancer tissues and cell lines.
Videira PA; Correia M; Malagolini N; Crespo HJ; Ligeiro D; Calais FM; Trindade H; Dall'Olio F
BMC Cancer; 2009 Oct; 9():357. PubMed ID: 19811634
[TBL] [Abstract][Full Text] [Related]
25. Tamoxifen enhances myoepithelial cell suppression of human breast carcinoma progression in vitro by two different effector mechanisms.
Shao ZM; Radziszewski WJ; Barsky SH
Cancer Lett; 2000 Sep; 157(2):133-44. PubMed ID: 10936673
[TBL] [Abstract][Full Text] [Related]
26. Downregulation of miR-224 and let-7i contribute to cell survival and chemoresistance in chronic myeloid leukemia cells by regulating ST3GAL IV expression.
Zhou H; Li Y; Liu B; Shan Y; Li Y; Zhao L; Su Z; Jia L
Gene; 2017 Aug; 626():106-118. PubMed ID: 28512058
[TBL] [Abstract][Full Text] [Related]
27. Altered mRNA expression of sialyltransferase in squamous cell carcinomas of the cervix.
Wang PH; Li YF; Juang CM; Lee YR; Chao HT; Tsai YC; Yuan CC
Gynecol Oncol; 2001 Oct; 83(1):121-7. PubMed ID: 11585423
[TBL] [Abstract][Full Text] [Related]
28. Changes in radiation sensitivity and steroid receptor content induced by hormonal agents and ionizing radiation in breast cancer cells in vitro.
Paulsen GH; Strickert T; Marthinsen AB; Lundgren S
Acta Oncol; 1996; 35(8):1011-9. PubMed ID: 9023387
[TBL] [Abstract][Full Text] [Related]
29. Molecular cloning of a novel alpha2,3-sialyltransferase (ST3Gal VI) that sialylates type II lactosamine structures on glycoproteins and glycolipids.
Okajima T; Fukumoto S; Miyazaki H; Ishida H; Kiso M; Furukawa K; Urano T; Furukawa K
J Biol Chem; 1999 Apr; 274(17):11479-86. PubMed ID: 10206952
[TBL] [Abstract][Full Text] [Related]
30. Characterization of mouse sialyltransferase genes: their evolution and diversity.
Takashima S
Biosci Biotechnol Biochem; 2008 May; 72(5):1155-67. PubMed ID: 18460788
[TBL] [Abstract][Full Text] [Related]
31. Differential expression of alpha-2,3-sialyltransferases and alpha-1,3/4-fucosyltransferases regulates the levels of sialyl Lewis a and sialyl Lewis x in gastrointestinal carcinoma cells.
Carvalho AS; Harduin-Lepers A; Magalhães A; Machado E; Mendes N; Costa LT; Matthiesen R; Almeida R; Costa J; Reis CA
Int J Biochem Cell Biol; 2010 Jan; 42(1):80-9. PubMed ID: 19781661
[TBL] [Abstract][Full Text] [Related]
32. Altered mRNA expressions of sialyltransferases in ovarian cancers.
Wang PH; Lee WL; Juang CM; Yang YH; Lo WH; Lai CR; Hsieh SL; Yuan CC
Gynecol Oncol; 2005 Dec; 99(3):631-9. PubMed ID: 16112178
[TBL] [Abstract][Full Text] [Related]
33. Altered subcellular localization of p53 in estrogen-dependent and estrogen-independent breast cancer cells.
Lilling G; Nordenberg J; Rotter V; Goldfinger N; Peller S; Sidi Y
Cancer Invest; 2002; 20(4):509-17. PubMed ID: 12094546
[TBL] [Abstract][Full Text] [Related]
34. Effect of tamoxifen and fulvestrant long-term treatments on ROS production and (pro/anti)-oxidant enzymes mRNA levels in a MCF-7-derived breast cancer cell line.
Badia E; Morena M; Lauret C; Boulahtouf A; Boulle N; Cavaillès V; Balaguer P; Cristol JP
Breast Cancer; 2016 Sep; 23(5):692-700. PubMed ID: 26193841
[TBL] [Abstract][Full Text] [Related]
35. Human alpha2,3-sialyltransferase (ST3Gal II) is a stage-specific embryonic antigen-4 synthase.
Saito S; Aoki H; Ito A; Ueno S; Wada T; Mitsuzuka K; Satoh M; Arai Y; Miyagi T
J Biol Chem; 2003 Jul; 278(29):26474-9. PubMed ID: 12716912
[TBL] [Abstract][Full Text] [Related]
36. Coordinated roles of ST3Gal-VI and ST3Gal-IV sialyltransferases in the synthesis of selectin ligands.
Yang WH; Nussbaum C; Grewal PK; Marth JD; Sperandio M
Blood; 2012 Aug; 120(5):1015-26. PubMed ID: 22700726
[TBL] [Abstract][Full Text] [Related]
37. Sialyltransferase specificity in selectin ligand formation.
Ellies LG; Sperandio M; Underhill GH; Yousif J; Smith M; Priatel JJ; Kansas GS; Ley K; Marth JD
Blood; 2002 Nov; 100(10):3618-25. PubMed ID: 12393657
[TBL] [Abstract][Full Text] [Related]
38. In vitro effects of estradiol, dydrogesterone, tamoxifen and cyclophosphamide on proliferation vs. death in human breast cancer cells.
Franke HR; Kole S; Ciftci Z; Haanen C; Vermes I
Cancer Lett; 2003 Feb; 190(1):113-8. PubMed ID: 12536084
[TBL] [Abstract][Full Text] [Related]
39. Cloning and sequencing of nineteen transcript isoforms of the human alpha2,3-sialyltransferase gene, ST3Gal III; its genomic organisation and expression in human tissues.
Grahn A; Barkhordar GS; Larson G
Glycoconj J; 2002 Mar; 19(3):197-210. PubMed ID: 12815231
[TBL] [Abstract][Full Text] [Related]
40. Human beta-galactoside alpha-2,3-sialyltransferase (ST3Gal III) attenuated Taxol-induced apoptosis in ovarian cancer cells by downregulating caspase-8 activity.
Huang S; Day TW; Choi MR; Safa AR
Mol Cell Biochem; 2009 Nov; 331(1-2):81-8. PubMed ID: 19415457
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
